Dutch DPA Issues No-Objection Opinion on Rehabilitation Care Experiment Regulation
Key Takeaways
- The Netherlands Data Protection Authority (AP) has reviewed the draft Regulation on the Experiment in Rehabilitation and Recovery Care (NR/REG-2701) under Article 36(4) GDPR and raised no objections.
- While this is a sector-specific healthcare regulation, it illustrates the AP's assessment framework for evaluating proportionality and data protection safeguards in draft legislation, which is instructive for compliance teams managing GDPR-related legislative consultations.
Deep Dive
This update reflects a routine but important exercise of the AP's advisory function under Article 36(4) of the GDPR, which requires public authorities to consult the data protection regulator when drafting legislation involving personal data processing. In this instance, the Dutch Healthcare Authority submitted a draft regulation governing an experimental rehabilitation and recovery care program, and the AP concluded that no changes or objections were necessary. This outcome signals that the draft met the AP's six-part assessment criteria: suitability, subsidiarity, proportionality, legal certainty, substantive/procedural safeguards, and binding force under national law.
For compliance teams, the substantive value of this document lies less in the specific healthcare regulation and more in the detailed assessment framework the AP has published as an appendix. This framework provides a transparent, reusable template that organizations operating in regulated sectors (healthcare, financial services, or other areas requiring statutory personal data processing) can use to pressure-test their own data processing frameworks or anticipate how the AP will evaluate forthcoming sector-specific regulations. The explicit references to Article 6(1) and 6(3) GDPR (lawful basis), Article 9 GDPR (special category data, relevant given the healthcare context), and Article 5 GDPR (core principles) reinforce the AP's continued emphasis on proportionality and necessity testing for any legislative measure authorizing personal data processing.
No specific compliance deadlines are imposed by this communication, as it is a legislative review opinion rather than a binding directive or enforcement action. However, the AP has indicated it will publish this review on its website within two weeks of the 25 August 2026 letter (i.e., by approximately 8 September 2026), making it part of the public record of Dutch regulatory practice.
Recommended actions for compliance professionals include monitoring the AP's published legislative opinions as a source of regulatory interpretation precedent, particularly where their organizations interact with Dutch public-sector data processing frameworks or special category data (health data) under Article 9 GDPR. Compliance and privacy teams involved in drafting or responding to sector-specific legislation should consider proactively applying the AP's six-point proportionality framework during internal privacy impact assessments. The overall risk impact here is low, as this is a non-binding advisory with no objections raised, but it serves as a useful benchmark for understanding regulatory expectations around health data processing and legislative compliance consultations in the Netherlands and, by extension, across EU member states with similar Article 36(4) consultation mechanisms.

